Product Overview
Best Anabolic Steroids stocks Cardarine from Zyvex Pharmaceuticals as an oral product filed under fat loss, with GW-501516 as its active substance. The shelf it sits on groups it with SARMs and that grouping is commercial, not chemical. GW-501516 activates a nuclear receptor called PPAR-delta; it binds no androgen receptor, it does not aromatise and it does not switch off natural testosterone production. A plan built around this product therefore has no place for an anti-estrogen, and no crash waits at the end of it.
Its history is the part most listings leave out. The compound was discovered in the 1990s by Ligand Pharmaceuticals working with GlaxoSmithKline and taken forward as a metabolic agent. The programme ended in 2007, after tumours developed quickly in several organs of the mice and rats that received 3 mg per kilogram each day, and WADA added the substance to the prohibited list in 2009 together with warnings that it is not safe. Both of those facts are treated here as product information rather than as a footnote, because the endurance stories that made the material popular were never matched by a completed human safety dossier.
What buyers are chasing is fuel use. Treated rodents ran much further before exhaustion, and that one result created the market. Human observations stay modest: shifts in blood lipids and in body composition are discussed in reviews and in user write-ups, timelines of two to four weeks appear in community posts, and no finished human trial supports them. In catalogued plans the product is an endurance layer beside a SARM such as Ligandrol LGD 4033 or Ostarine MK 2866, run short and at low dose exactly because the rodent signal is not a comfortable one.
How the Compound Behaves
PPAR-delta governs a set of genes tied to fatty acid oxidation. A synthetic ligand that switches those genes on moves working muscle toward burning fat for fuel and away from storing it, which is the whole of the mechanistic story and the source of the tablet-instead-of-cardio reputation. Nothing about that pathway adds muscle protein, and nothing about it removes anabolic drive from the system.
Clearance is poorly documented. The cited sources publish no elimination half-life for GW-501516, and no hepatic toxicity rating belongs on a PPAR agonist, so the short card on this page reports Not established in both rows rather than inventing a figure for symmetry with the steroid pages. Detection is the single well measured item and it is long: urine keeps showing sulfone metabolites for as long as 40 days after one dose, even though the unchanged drug is gone within about five days. For anyone in a testing pool, the 40 day number is the one that matters.
A steady level is easy to hold, since the tablet is taken once a day and the material is not injected. That simplicity is also the reason it gets combined too freely. Each extra compound in a stack adds its own unknowns to a substance whose human profile is already thin, and the section on side effects below treats the animal finding as the planning constraint rather than the headache reports.
Dosage Protocol
The figures below restate practice described in sources and user reports for GW-501516. They are reference points for a research plan, not a prescription, and no approved dose exists for this substance anywhere.
| Level | Daily amount | Length | Notes |
|---|---|---|---|
| Beginner | 10 mg | 8 weeks | The lowest figure in the sources; a single oral dose each day |
| Intermediate | 10-20 mg | 8-12 weeks | The band that appears most often in write-ups; morning intake |
| Advanced | 20 mg | up to 12 weeks | Ceiling of the described range; nothing above it is documented |
| Female | No confirmed protocol | - | The sources describe no separate female schedule for this compound |
| Administration | Oral, once daily | - | Swallowed with a meal; no injection, no site rotation, no solvent |
One human figure sits behind the band in the table: a forensic hair analysis case report describing intake of 10-20 mg per day for the compound. Everything above 20 mg is extrapolation, and the animal cancer finding came from a dose that translates into a far higher human equivalent than the table allows.
Suggested Protocols
None of these arrangements has been tested as a combination. They describe the shapes in which the product turns up on a training plan, with each partner contributing a different job.
What to Expect
- Weeks 1 to 2. Very little that can be measured. Appetite, weight and hormone values stay where they were, and any change at this point is training, not the tablet.
- Weeks 2 to 4. The window in which community write-ups place the first endurance change: longer sessions before fatigue, quicker recovery between efforts on the same calories.
- Weeks 4 to 8. Steadier conditioning and, in reviews, a shift in blood lipids described as favourable. Scale weight barely moves unless food intake does.
- The limit. The rodent cancer finding at 3 mg per kilogram per day is the reason runs are short. There is no human study that defines a safe ceiling, so 8 weeks is the usual length and 12 weeks the outer edge.
- The thin record. Human safety data remain scarce. Headache, nausea and fatigue are the complaints that appear in reports, and they are tied to dose far more often than to duration.
- Coming off. No hormonal crash and no shutdown to reverse. The training effect fades over the following weeks, and the one marker that lingers is the urine metabolite, up to 40 days after the final dose.
Side Effects and Management
Cycle Support and Recovery
There is no post-cycle therapy for this product in the usual sense, and the reason is structural. Recovery drugs work by restarting a suppressed gonadotropin signal, and a PPAR-delta agonist never suppresses one. Copying a steroid recovery from another page onto this plan would add two compounds with their own side effects and nothing to act on.
Buying Cardarine GW-501516 by Zyvex Pharmaceuticals
The pack is listed inside the Zyvex Pharmaceuticals range with its oral format and dosing notes on the card, so the daily amount can be fixed before the order goes in. Neighbours on the same shelf include Semaglutide 10 and Retatrutide 20 for appetite-led approaches to the same goal, and Clenbuterol for the stimulant route. Payment methods and shipping regions are shown at checkout, parcels leave in plain packaging, and stock questions can be answered before the order is placed.
